Bolaris S, Margarity M, Valcana T
Department of Biology, University of Patras, Greece.
Biol Psychiatry. 1995 Jan 15;37(2):106-11. doi: 10.1016/0006-3223(94)00171-X.
The therapeutic effects of lithium in mania and depression are thought to be mediated by its effects on plasma thyroid hormone (T4, T3) levels. Inasmuch as T3 affects transcription by binding with its nuclear receptors, in this study we examined whether Li+ alters T3 nuclear binding. Although plasma T3 and T4 levels were not affected, 125I-T3 uptake was decreased, and both in vivo and in vitro studies showed a significant increase in nuclear T3 binding in brain and liver tissue. This increase was shown to reflect an increase in maximal binding density. On the basis of these findings, it is proposed that Li+ exerts its action by inducing "cellular hypothyroidism." Integrating existing information on thyroid hormones and affective diseases and the effects of hypothyroidism on neurotransmitters thought to be altered in mania and depression, this hypothesis is supported and contributes to understanding of the effects of LiCl and thyroid hormones in affective diseases.
锂对躁狂和抑郁的治疗作用被认为是通过其对血浆甲状腺激素(T4、T3)水平的影响来介导的。鉴于T3通过与其核受体结合来影响转录,在本研究中,我们检测了Li⁺是否会改变T3的核结合。尽管血浆T3和T4水平未受影响,但¹²⁵I-T3摄取减少,体内和体外研究均显示脑和肝组织中的核T3结合显著增加。这种增加表明最大结合密度增加。基于这些发现,有人提出Li⁺通过诱导“细胞性甲状腺功能减退”发挥其作用。整合关于甲状腺激素与情感性疾病的现有信息以及甲状腺功能减退对被认为在躁狂和抑郁中发生改变的神经递质的影响,这一假设得到支持,并有助于理解LiCl和甲状腺激素在情感性疾病中的作用。